Dabrafenib mesylate
N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide;methanesulfonic acid
Molecular Identity
Dabrafenib mesylate
N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide;methanesulfonic acid
PubChem CID: 44516822
Dabrafenib mesylate is a methanesulfonate (mesylate) salt prepared from equimolar amounts of dabrafenib and methanesulfonic acid. Used for treatment of metastatic melanoma. It has a role as an antineoplastic agent and a B-Raf inhibitor. It contains a dabrafenib.
2D Structure
Properties
C24H24F3N5O5S3
Molecular Formula
615.70
Molecular Weight
g/mol
615.0892
Exact Mass
Da
210
TPSA
May have limited oral absorption
3
H-Bond Donors
14
H-Bond Acceptors
910
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Dabrafenib mesylate1195768-06-9TaflinarUNII-B6DC89I63EGSK 2118436BGSK-2118436BDabrafenib methanesulfonateGSK2118436BB6DC89I63Edabrafenib monomesylateGSK-2118436B MESYLATEGSK2118436 Methane sulfonate saltGSK2118436B, methane sulfonate saltGSK-2118436 METHANESULFONATE SALTBenzenesulfonamide, N-[3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-, methanesulfonate (1:1)
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Dabrafenib mesylate
Loading drug network...